| 1 | (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydropyrimidine-5-carbonitrile | - | - | - | - | [1] 231 231 💬
|
| 2 | 20-valent pneumococcal conjugate vaccine | - | - | - | - | [1] 231 231 💬
|
| 3 | 4-PBA | - | - | - | - | [1] 231 231 💬
|
| 4 | [ARO-AAT] | - | - | - | - | [1] 231 231 💬
|
| 5 | AAV8hAAT(AVL) | - | - | - | - | [1] 231 231 💬
|
| 6 | Abdominal ultrasound | - | - | - | - | [2] 19 19, 231 💬
|
| 7 | Acetaminophen | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [19] 11 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
|
| 8 | ADS-001 | - | - | - | - | [1] 231 231 💬
|
| 9 | Aerosolized human Alpha-1 Antitrypsin | - | - | - | - | [1] 231 231 💬
|
| 10 | AIR-001 MD dose level 1 | - | - | - | - | [1] 231 231 💬
|
| 11 | AIR-001 MD dose level 2 | - | - | - | - | [1] 231 231 💬
|
| 12 | AIR-001 MD dose level 3 | - | - | - | - | [1] 231 231 💬
|
| 13 | AIR-001 MD dose level 4 | - | - | - | - | [1] 231 231 💬
|
| 14 | AIR-001 MD dose level 5 | - | - | - | - | [1] 231 231 💬
|
| 15 | AIR-001 MD dose level 6 | - | - | - | - | [1] 231 231 💬
|
| 16 | AIR-001 SAD dose level 1 | - | - | - | - | [1] 231 231 💬
|
| 17 | AIR-001 SAD dose level 2 | - | - | - | - | [1] 231 231 💬
|
| 18 | AIR-001 SAD dose level 3 | - | - | - | - | [1] 231 231 💬
|
| 19 | AIR-001 SAD dose level 4 | - | - | - | - | [1] 231 231 💬
|
| 20 | Albumin (Human) 20%, United States Pharmacopeia (USP) | - | - | - | - | [1] 231 231 💬
|
| 21 | Albuterol | [1] Albuterol Albuterol | [2] Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [9] 12 12, 13, 86, 89, 113, 231, 256, 299, 340 💬
|
| 22 | Albuterol inhaler. | [1] Albuterol Albuterol | [2] Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 231 231, 299 💬
|
| 23 | ALN-61444 | - | - | - | - | [1] 231 231 💬
|
| 24 | ALN-77412 | - | - | - | - | [1] 231 231 💬
|
| 25 | ALN-AAT | - | - | - | - | [1] 231 231 💬
|
| 26 | ALN-AAT02 | - | - | - | - | [1] 231 231 💬
|
| 27 | Alpha 1-Antitrypsin | - | - | - | - | [2] 231 231, 298 💬
|
| 28 | Alpha 1-proteinase inhibitor (human) | - | - | - | - | [1] 231 231 💬
|
| 29 | Alpha-1 15% | - | - | - | - | [1] 231 231 💬
|
| 30 | Alpha-1 Antitrypsin (AAT) | - | - | - | - | [1] 231 231 💬
|
| 31 | Alpha-1 Antitrypsin (human) | - | - | - | - | [1] 231 231 💬
|
| 32 | Alpha-1 MP | - | - | - | - | [1] 231 231 💬
|
| 33 | Alpha-1 proteinase inhibitor (human) | - | - | - | - | [1] 231 231 💬
|
| 34 | ALPHA-1-ANTITRYPSIN | - | - | - | - | [1] 231 231 💬
|
| 35 | Alpha1-Proteinase Inhibitor | - | - | - | - | [1] 231 231 💬
|
| 36 | Alpha1-Proteinase Inhibitor (Human) | - | - | - | - | [2] 231 231, 299 💬
|
| 37 | ALVELESTAT | [1] Alvelestat Alvelestat | - | - | - | [1] 231 231 💬
|
| 38 | Alvelestat (MPH966) | [1] Alvelestat Alvelestat | - | - | - | [1] 231 231 💬
|
| 39 | Alvelestat oral tablet - dose 1 | [1] Alvelestat Alvelestat | - | - | - | [1] 231 231 💬
|
| 40 | Alvelestat oral tablet - dose 2 | [1] Alvelestat Alvelestat | - | - | - | [1] 231 231 💬
|
| 41 | Alvelestat tosylate | [1] Alvelestat Alvelestat | - | - | - | [1] 231 231 💬
|
| 42 | API-AAT | - | - | - | - | [1] 231 231 💬
|
| 43 | API-AAT, AD00370, ARC-AAT, API drug Substance | - | - | - | - | [1] 231 231 💬
|
| 44 | ARC-AAT | - | - | - | - | [1] 231 231 💬
|
| 45 | ARC-AAT Injection | - | - | - | - | [1] 231 231 💬
|
| 46 | ARO-AAT | [1] Fazirsiran Fazirsiran | - | - | - | [1] 231 231 💬
|
| 47 | ARO-AAT Injection | - | - | - | - | [1] 231 231 💬
|
| 48 | Aspirin | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] Aspirin
Aspirin
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [10] 22 22, 34, 48, 49, 51, 63, 86, 158, 210, 231 💬
|
| 49 | BEAM-302 | - | - | - | - | [1] 231 231 💬
|
| 50 | Belcesiran | [1] Belcesiran Belcesiran | - | - | - | [1] 231 231 💬
|
| 51 | Biological NTLA-3001 | - | - | - | - | [1] 231 231 💬
|
| 52 | Blood draw | - | - | - | - | [16] 3 3, 6, 13, 19, 46, 48, 49, 51, 58, 65, 67, 193, 215, 231, 298, 299 💬
|
| 53 | Blood draw. | - | - | - | - | [2] 231 231, 299 💬
|
| 54 | BMN 349 | - | - | - | - | [1] 231 231 💬
|
| 55 | Carbamazepine | [1] Carbamazepine Carbamazepine | [1] Carbamazepine
Carbamazepine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [6] 6 6, 13, 137, 145, 158, 231 💬
|
| 56 | Diagnostic Test: Blood sampling | - | - | - | - | [8] 49 49, 51, 65, 74, 97, 127, 231, 299 💬
|
| 57 | Dose of 60 mg/kg alpha1-proteinase inhibitor | - | - | - | - | [1] 231 231 💬
|
| 58 | Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor | - | - | - | - | [1] 231 231 💬
|
| 59 | Drug-Carbamazepine (Tegretol XR) | [1] Carbamazepine Carbamazepine | [1] Carbamazepine
Carbamazepine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 231 231 💬
|
| 60 | Fazirsiran | [1] Fazirsiran Fazirsiran | - | - | - | [1] 231 231 💬
|
| 61 | Fazirsiran (TAK-999, also referred to as ARO-AAT) Injection | [1] Fazirsiran Fazirsiran | - | - | - | [1] 231 231 💬
|
| 62 | Fazirsiran (TAK-999, ARO-AAT) Injection | [1] Fazirsiran Fazirsiran | - | - | - | [1] 231 231 💬
|
| 63 | Fazisiran Injection | - | - | - | - | [1] 231 231 💬
|
| 64 | Fentanyl | [1] Fentanyl Fentanyl | [3] Fentanyl
Fentanyl
,
Fentanyl citrate
,
Fentanyl hydrochloride
💬
| [1] OPRM1 OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [6] 46 46, 70, 97, 215, 231, 298 💬
|
| 65 | Genetic: ADVM-043 | - | - | - | - | [1] 231 231 💬
|
| 66 | Genetic: genetic sequencing | - | - | - | - | [2] 40 40, 231 💬
|
| 67 | Genetic: rAAV2-CB-hAAT Gene Vector | - | - | - | - | [1] 231 231 💬
|
| 68 | Glassia | - | - | - | - | [1] 231 231 💬
|
| 69 | History and physical | - | - | - | - | [1] 231 231 💬
|
| 70 | History and physical exam. | - | - | - | - | [2] 231 231, 299 💬
|
| 71 | Hyaluronic acid | [1] Hyaluronic acid Hyaluronic acid | [2] Hyaluronate sodium
Hyaluronate sodium
,
Hyaluronic acid
💬
| - | - | [5] 46 46, 53, 70, 226, 231 💬
|
| 72 | Hyaluronic Acid Inhalation Solution | [1] Hyaluronic acid Hyaluronic acid | [2] Hyaluronate sodium
Hyaluronate sodium
,
Hyaluronic acid
💬
| - | - | [1] 231 231 💬
|
| 73 | INBRX-101 | [1] INBRX-101 INBRX-101 | - | - | - | [1] 231 231 💬
|
| 74 | INBRX-101/rhAAT-Fc | [1] INBRX-101 INBRX-101 | - | - | - | [1] 231 231 💬
|
| 75 | Intravenous catheter | - | - | - | - | [1] 231 231 💬
|
| 76 | Kamada -AAT for Inhalation or inhaled AAT (AAT) | - | - | - | - | [1] 231 231 💬
|
| 77 | Kamada -AAT for Inhalation or inhaled AAT (AAT)Pharmaceutical Form: Nebuliser solutionINN or Proposed INN: Alpha-1 Antitrypsin (AAT)CAS Number: 9041-92-3Current Sponsor code: Kamada-AATConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 20-Pharmaceutical form of the placebo: Nebuliser solutionRoute of administration of the placebo: Inhalation use | - | - | - | - | [1] 231 231 💬
|
| 78 | Kamada-AAT for inhalation | - | - | - | - | [1] 231 231 💬
|
| 79 | Kamada-AAT for Inhalation, 160mg | - | - | - | - | [1] 231 231 💬
|
| 80 | Kamada-AAT for Inhalation, 80mg | - | - | - | - | [1] 231 231 💬
|
| 81 | Kamada-API | - | - | - | - | [1] 231 231 💬
|
| 82 | KB408 (Nebulization) | - | - | - | - | [1] 231 231 💬
|
| 83 | KRRO-110 | - | - | - | - | [1] 231 231 💬
|
| 84 | Lidocaine | [1] Lidocaine Lidocaine | [3] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [14] 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
| 85 | Liver biopsy | - | - | - | - | [3] 171 171, 231, 240 💬
|
| 86 | Lorazepam | [1] Lorazepam Lorazepam | [1] Lorazepam
Lorazepam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [2] 36 36, 231 💬
|
| 87 | Midazolam | [1] Midazolam Midazolam | [3] Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [14] 2 2, 3, 6, 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
|
| 88 | MPH966 | - | - | - | - | [2] 228 228, 231 💬
|
| 89 | None assigned | - | - | - | - | [2] 231 231, 299 💬
|
| 90 | OctaAlpha1 | - | - | - | - | [1] 231 231 💬
|
| 91 | Ondansetron | [1] Ondansetron Ondansetron | [2] Ondansetron
Ondansetron
,
Ondansetron hydrochloride hydrate
💬
| [5] HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬 | [5] 6 6, 97, 98, 107, 231 💬
|
| 92 | OsrhAAT 1 mg/kg IV | - | - | - | - | [1] 231 231 💬
|
| 93 | OsrhAAT 10 mg/kg IV | - | - | - | - | [1] 231 231 💬
|
| 94 | OsrhAAT 20 mg/kg IV | - | - | - | - | [1] 231 231 💬
|
| 95 | OsrhAAT 3 mg/kg IV | - | - | - | - | [1] 231 231 💬
|
| 96 | OsrhAAT 40 mg/kg IV | - | - | - | - | [1] 231 231 💬
|
| 97 | OsrhAAT 60 mg/kg IV | - | - | - | - | [1] 231 231 💬
|
| 98 | Other: Hyperpolarized 129Xe MRI | - | - | - | - | [2] 84 84, 231 💬
|
| 99 | Other: Liquid Alpha1-PI | - | - | - | - | [1] 231 231 💬
|
| 100 | Other: Liver questionnaire | - | - | - | - | [1] 231 231 💬
|
| 101 | Other: Sterile Normal Saline (0.9% NaCl) | - | - | - | - | [1] 231 231 💬
|
| 102 | Other: Withdrawal from alpha1 antitrypsin replacement therapy | - | - | - | - | [1] 231 231 💬
|
| 103 | Oxycodone | [1] Oxycodone Oxycodone | [3] Oxycodone hydrochloride
Oxycodone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 6 6, 13, 46, 70, 226, 231, 298 💬
|
| 104 | Oxycodone/Acetaminophen | [2] Acetaminophen Acetaminophen, Oxycodone | [4] Acetaminophen
Acetaminophen
,
Oxycodone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
💬
| [5] OPRD1 OPRD1, OPRK1, OPRM1, PTGS1, PTGS2 💬
| [30] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Estrogen signaling pathway, Hormone signaling, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Sphingolipid signaling pathway, TNF signaling pathway, VEGF signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 231 231 💬
|
| 105 | PHP-303 | - | - | - | - | [1] 231 231 💬
|
| 106 | Prolastin | - | - | - | - | [1] 231 231 💬
|
| 107 | Prolastin-C | - | - | - | - | [2] 231 231, 298 💬
|
| 108 | Prolastin-C, 120 mg/kg | - | - | - | - | [1] 231 231 💬
|
| 109 | Prolastin-C, 60 mg/kg | - | - | - | - | [1] 231 231 💬
|
| 110 | Pulmonary function testing. | - | - | - | - | [2] 231 231, 299 💬
|
| 111 | RAAV1-CB-hAAT | [1] rAAV1-CB-hAAT rAAV1-CB-hAAT | - | - | - | [1] 231 231 💬
|
| 112 | RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR EXPRESSING THE HUMAN ALPHA-1-ANTITRYPSIN GENE | - | - | - | - | [1] 231 231 💬
|
| 113 | Retinoic Acid Receptor gamma Agonist | - | - | - | - | [1] 231 231 💬
|
| 114 | RO3300074 | - | - | - | - | [1] 231 231 💬
|
| 115 | SAR447537 | - | - | - | - | [1] 231 231 💬
|
| 116 | TAK-999, ARO-AAT | [1] Fazirsiran Fazirsiran | - | - | - | [1] 231 231 💬
|
| 117 | TSRA-196 | - | - | - | - | [1] 231 231 💬
|
| 118 | VX-634 | - | - | - | - | [1] 231 231 💬
|
| 119 | VX-668 | - | - | - | - | [1] 231 231 💬
|
| 120 | VX-814 | - | - | - | - | [1] 231 231 💬
|
| 121 | VX-864 | - | - | - | - | [1] 231 231 💬
|
| 122 | VX864 | - | - | - | - | [1] 231 231 💬
|
| 123 | WVE-006 | - | - | - | - | [1] 231 231 💬
|
| 124 | YOLT-202 | - | - | - | - | [1] 231 231 💬
|
| 125 | Zemaira | - | - | - | - | [1] 231 231 💬
|